FH-TCR-Tmesothelin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FH-TCR-Tmesothelin, covering 2025-04-20 to 2025-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]